CQMC Announces Updates to Eight Core Measure Sets
Update includes implementation guidance to facilitate widescale adoption.
All News
Sticker Shock: New Research Shows an Average List Price Increase of Over 200% for Top Part D Drugs
Research released by AARP’s Public Policy Institute (PPI), list prices for the top 25 Medicare Part D drugs have increased by an average of 226%.
Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
New Health Affairs Study: Competition In Pharmaceuticals Leads to Lower Prices, Reduced Drug Spending
A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.